Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
Pulmonary administration route has been extensively exploited for the treatment of local lung diseases such as asthma, chronic obstructive pulmonary diseases and respiratory infections, and systemic diseases such as diabetes. Most inhaled medicines could be cleared rapidly from the lungs and their t...
Main Authors: | Yi Guo, Hriday Bera, Changzhi Shi, Li Zhang, Dongmei Cun, Mingshi Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383521001817 |
Similar Items
-
Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
by: Imco Sibum, et al.
Published: (2019-05-01) -
Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
by: Iching G. Yu, et al.
Published: (2021-04-01) -
Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with <span style="font-variant: small-caps">L</span>-Leucine or Trileucine
by: Imco Sibum, et al.
Published: (2019-12-01) -
Dry powder antibiotics for inhaled anti-tuberculosis therapy
by: Son, Yoen Ju
Published: (2011) -
Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
by: S. Chennakesavulu, et al.
Published: (2018-01-01)